Literature DB >> 11045782

Dietary intake of isothiocyanates: evidence of a joint effect with glutathione S-transferase polymorphisms in lung cancer risk.

M R Spitz1, C M Duphorne, M A Detry, P C Pillow, C I Amos, L Lei, M de Andrade, X Gu, W K Hong, X Wu.   

Abstract

Isothiocyanates (ITCs) are nonnutrient compounds in cruciferous vegetables with anticarcinogenic properties. One proposed mechanism for their protective action is through down-regulation of cytochrome P-450 biotransformation enzyme levels and induction of phase II detoxifying enzymes. Because ITCs also serve as a substrate for GSTs, we evaluated dietary intake of ITCs and GSTM1 and GSTT1 genotype information in a lung cancer case-control study. There were 503 newly diagnosed lung cancer cases (264 men and 239 women) identified from The University of Texas M. D. Anderson Cancer Center and 465 controls (252 men and 213 women) recruited from enrollees in a local managed care organization. Subjects had an in-person interview including a semiquantitative food frequency questionnaire, and blood samples were obtained for genotyping. Cases reported significantly lower ITC intake per day compared with controls (P = 0.009). There was no main effect associated with the GSTM1 null genotype [odds ratio (OR) = 1.09]. However, there was a statistically significant OR of 1.41 associated with the GSTT1 null genotype. On stratified analysis, low ITC intake and the GSTM1 null genotype were associated with increased lung cancer risk in current smokers, with an OR of 2.22 [confidence interval (CI) = 1.20-4.10). For current smokers with the GSTT1 null genotype, the OR with low ITC intake was 3.19 (CI = 1.54-6.62). The comparable OR in the presence of both null genotypes was 5.45 (CI = 1.72-17.22). These effects were not demonstrable for former smokers by GSTM1 genotype, although the risk for low ITC intake and GSTT1 null genotype was 1.79 (CI = 0.95-3.37). Thus, current smokers who are homozygous null for the GST null genotype and who consume less carcinogenic blocking compounds are at higher lung cancer risk. Some of the inconsistencies reported in the role of GST genotypes in lung cancer risk could be due to unexpected confounding from dietary factors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11045782

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  44 in total

Review 1.  Dietary Sulforaphane in Cancer Chemoprevention: The Role of Epigenetic Regulation and HDAC Inhibition.

Authors:  Stephanie M Tortorella; Simon G Royce; Paul V Licciardi; Tom C Karagiannis
Journal:  Antioxid Redox Signal       Date:  2014-12-19       Impact factor: 8.401

Review 2.  Mechanisms of action of isothiocyanates in cancer chemoprevention: an update.

Authors:  Sandi L Navarro; Fei Li; Johanna W Lampe
Journal:  Food Funct       Date:  2011-09-21       Impact factor: 5.396

3.  Assessment of cumulative evidence for the association between glutathione S-transferase polymorphisms and lung cancer: application of the Venice interim guidelines.

Authors:  Scott M Langevin; John P A Ioannidis; Paolo Vineis; Emanuela Taioli
Journal:  Pharmacogenet Genomics       Date:  2010-10       Impact factor: 2.089

Review 4.  Diet and prostate cancer: mechanisms of action and implications for chemoprevention.

Authors:  Vasundara Venkateswaran; Laurence H Klotz
Journal:  Nat Rev Urol       Date:  2010-07-20       Impact factor: 14.432

Review 5.  Phenethyl isothiocyanate: a comprehensive review of anti-cancer mechanisms.

Authors:  Parul Gupta; Stephen E Wright; Sung-Hoon Kim; Sanjay K Srivastava
Journal:  Biochim Biophys Acta       Date:  2014-08-23

6.  Assessment of DNA damage and repair in adults consuming allyl isothiocyanate or Brassica vegetables.

Authors:  Craig S Charron; Beverly A Clevidence; George A Albaugh; Matthew H Kramer; Bryan T Vinyard; John A Milner; Janet A Novotny
Journal:  J Nutr Biochem       Date:  2012-08-16       Impact factor: 6.048

Review 7.  Dietary chemoprevention strategies for induction of phase II xenobiotic-metabolizing enzymes in lung carcinogenesis: A review.

Authors:  Xiang-Lin Tan; Simon D Spivack
Journal:  Lung Cancer       Date:  2009-01-31       Impact factor: 5.705

8.  Dietary boron and hormone replacement therapy as risk factors for lung cancer in women.

Authors:  S Mahabir; M R Spitz; S L Barrera; Y Q Dong; C Eastham; M R Forman
Journal:  Am J Epidemiol       Date:  2008-03-14       Impact factor: 4.897

9.  Serum glutathione transferase does not respond to indole-3-carbinol: A pilot study.

Authors:  Daniel R McGrath; Hamid Frydoonfar; Joshua J Hunt; Chris J Dunkley; Allan D Spigelman
Journal:  Ther Clin Risk Manag       Date:  2010-05-25       Impact factor: 2.423

10.  Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms and gastric cancer risk: a prospective study of men in Shanghai, China.

Authors:  Kristin A Moy; Jian-Min Yuan; Fung-Lung Chung; Xue-Li Wang; David Van Den Berg; Renwei Wang; Yu-Tang Gao; Mimi C Yu
Journal:  Int J Cancer       Date:  2009-12-01       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.